Skip navigation

Stem cell research

A stem cell is a kind of 'starter cell' that has the potential to develop into many different cell types in the body. When a stem cell multiplies, the resulting cells either remain as stem cells or - under the right conditions - can develop more specialised functions, for example changing into muscle, blood or nerve cells.

Scientists now believe that stem cells may play a direct role in the development of cancer, as some tumours are thought to develop from faulty stem cells. This has led to the idea of 'cancer stem cells', which have now been identified in a range of cancer types, including bowel, breast and prostate cancer.

The challenge for scientists is to understand where cancer stem cells come from, and to find ways to target them with effective treatments. To do this, they need to study the molecular makeup and behaviour of stem cells in great detail.

Our researchers’ work will tell us more about stem cells, from how they multiply and change into other types of cell, to what causes them to grow out of control and cause cancer.

Below are some of the highlights of our stem cell work.

Bowel cancer

Dr Owen Sansom Dr Owen Sansom

Wnt Signalling and Colorectal Cancer Group

Beatson Institute for Cancer Research, Glasgow

Understanding the molecular mistakes in bowel cancer

Dr Owen Sansom heads a research group at our Beatson Institute for Cancer Research. He and his team are investigating the molecular changes that happen in bowel cells that ultimately lead to bowel cancer. Finding out more about how it develops will help scientists to find new ways to prevent and treat the disease.

Dr Doug Winton Dr Doug Winton

Stem Cell Biology of the Intestine Group

Cambridge Research Institute, Cambridge

Studying stem cells in bowel cancer

Dr Doug Winton runs a research group at our Cambridge Research Institute. He and his team are investigating how stem cells can fuel the growth of bowel cancer.

Brain tumours

Dr Steven Pollard Dr Steven Pollard

Wellcome Trust Centre for Stem Cell Research

University of Cambridge, Cambridge

Studying stem cells in brain tumours

Dr Steven Pollard is at the forefront of research into brain tumours. His work focuses on the exciting new area of cancer stem cells. These specialised cells only make up a small proportion of the whole tumour but are believed to act as the driving force behind many cancers. Dr Pollard is investigating how cancer stem cells in the brain contribute to the development of brain tumours. He plans to use this information to find effective new ways to treat this disease.

Breast cancer

Dr John Stingl Dr John Stingl

Mammary Stem Cell Laboratory

Cambridge Research Institute, Cambridge

Studying stem cells in breast cancer

Dr John Stingl runs the Mammary Stem Cell Laboratory at our Cambridge Research Institute. His team is studying stem cells that fuel the growth of breast cancer. Understanding these elusive cells will lead to more effective treatments for this disease in the future.

Leukaemia

Dr Dominique Bonnet Dr Dominique Bonnet

Haematopoietic Stem Cell Laboratory

Cancer Research UK London Research Institute, London

Stem cells and leukaemia

Dr Dominique Bonnet and her team at our London Research Institute are looking for ways to improve treatments for leukaemia. They are exploring the role of special cells in the blood, known as haematopoietic stem cells.These fascinating cells can transform into many different types of mature blood cell, including red blood cells that carry oxygen and white blood cells that fight infection.

Skin cancer

Prof Fiona Watt Prof Fiona Watt

Epithelial Cell Biology

Cambridge Research Institute, Cambridge

Getting under the skin

Professor Fiona Watt, the Deputy Director of our Cambridge Research Institute, is studying normal skin cells in order to understand what goes wrong in skin cancer. In particular, she is carrying out pioneering research into skin stem cells. These long-lived cells can multiply to produce many different types of skin cell and are believed to play a central role in the development of skin cancer.